Blue Jet Healthcare Limited (BLUEJET.NS)
INR 723.25
(1.7%)
INR 723.25
(1.7%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.13 Billion INR | 18.3% |
| 2022 | 1.8 Billion INR | -5.87% |
| 2021 | 1.91 Billion INR | -2.35% |
| 2020 | 1.96 Billion INR | 13.79% |
| 2019 | 1.72 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.57 Billion INR | 130.41% |
| 2024 Q1 | -8.45 Billion INR | -495.66% |
| 2023 FY | 2.13 Billion INR | 18.3% |
| 2023 Q1 | 1.78 Billion INR | -1.36% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.89 Billion INR | 6.61% |
| 2023 Q4 | 2.13 Billion INR | 0.0% |
| 2022 Q1 | 1.82 Billion INR | 0.0% |
| 2022 Q4 | 1.8 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Biocon Limited | 307.95 Billion INR | 99.306% |
| Concord Biotech Limited | 1.74 Billion INR | -22.727% |
| Dishman Carbogen Amcis Limited | 39.53 Billion INR | 94.597% |
| Jubilant Ingrevia Limited | 19.94 Billion INR | 89.289% |
| Lyka Labs Limited | 884.58 Million INR | -141.495% |
| Panacea Biotec Limited | 4.02 Billion INR | 46.863% |
| Piramal Pharma Limited | 74 Billion INR | 97.113% |
| SMS Lifesciences India Limited | 1.96 Billion INR | -8.503% |
| Supriya Lifescience Limited | 1.05 Billion INR | -101.779% |
| Syngene International Limited | 18.93 Billion INR | 88.72% |
| TAKE Solutions Limited | 969.78 Million INR | -120.28% |
| Zota Health Care Limited | 1.38 Billion INR | -54.406% |